encenicline (EVP-6124) - Forum Pharmaceuticals, Mitsubishi Tanabe
Forum Pharmaceuticals: Needham Healthcare Conference (Forum Pharmaceuticals) - Apr 23, 2015 - Anticipated submission of supplemental NDA for Alzheimers disease in 2017; Anticipated approval for Alzheimers disease in 2018; Anticipated launch for Alzheimers disease in 2018 
Anticipated launch • Anticipated sNDA Alzheimer's Disease
http://wsw.com/webcast/needham71/forp/
 
Apr 23, 2015
 
 
fd2359f9-aa92-4675-b047-f20e282c1c7f.jpg